These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36032469)

  • 1. CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus.
    Ndikom BC; Ergoren MC; Sayan M; Mocan G; Fahrioğlu U
    Afr Health Sci; 2022 Mar; 22(1):361-366. PubMed ID: 36032469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5-Δ32 gene variant frequency in the Turkish Cypriot population.
    Fahrioglu U; Ergoren MC; Mocan G
    Braz J Microbiol; 2020 Dec; 51(4):1711-1717. PubMed ID: 32734471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria.
    Ekere EF; Useh MF; Okoroiwu HU; Mirabeau TY
    BMC Infect Dis; 2020 Jan; 20(1):5. PubMed ID: 31900106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between CCR5
    Martínez-Bonet M; González-Serna A; Clemente MI; Morón-López S; Díaz L; Navarro M; Puertas MC; Leal M; Ruiz-Mateos E; Martinez-Picado J; Muñoz-Fernández MA
    Clin Microbiol Infect; 2017 May; 23(5):318-324. PubMed ID: 28042001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
    Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
    J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection.
    Lucotte G; Dieterlen F
    Infect Genet Evol; 2003 Nov; 3(4):293-5. PubMed ID: 14636691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of the CCR5-delta32 allele in Brazilian populations: A systematic literature review and meta-analysis.
    Silva-Carvalho WH; de Moura RR; Coelho AV; Crovella S; Guimarães RL
    Infect Genet Evol; 2016 Sep; 43():101-7. PubMed ID: 27208805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
    Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
    Gastroenterology; 2002 Jun; 122(7):1721-8. PubMed ID: 12055576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
    Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
    J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
    Nkenfou CN; Mekue LC; Nana CT; Kuiate JR
    BMC Res Notes; 2013 Jul; 6():288. PubMed ID: 23880174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.
    Solloch UV; Lang K; Lange V; Böhme I; Schmidt AH; Sauter J
    Hum Immunol; 2017 Nov; 78(11-12):710-717. PubMed ID: 28987960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of CCR5 Gene 32-bp deletion in Pakistani ethnic groups.
    Khaliq S; Hameed A; Ayub Q; Mazhar K; Mohyuddin A; Mansoor A; Mehdi SQ
    Genet Test; 2002; 6(2):123-7. PubMed ID: 12215252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups.
    Wang FS; Hong WG; Cao Y; Liu MX; Jin L; Hu LP; Wang Z; Feng TJ; Hou J; Zhang B; Shi M; Xu DP; Lei ZY; Wang B; Liu ZD; Ye JJ; Peng L; Qiu Y; Winkler C
    J Acquir Immune Defic Syndr; 2003 Feb; 32(2):124-30. PubMed ID: 12571520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
    Takácová M; Nogová P; Hábeková M; Staneková D
    Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.
    Marmor M; Sheppard HW; Donnell D; Bozeman S; Celum C; Buchbinder S; Koblin B; Seage GR;
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):472-81. PubMed ID: 11511825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission.
    Ometto L; Zanchetta M; Mainardi M; De Salvo GL; Garcia-Rodriguez MC; Gray L; Newell ML; Chieco-Bianchi L; De Rossi A
    AIDS; 2000 Aug; 14(12):1721-9. PubMed ID: 10985308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
    van Rij RP; Portegies P; Hallaby T; Lange JM; Visser J; de Roda Husman AM; van 't Wout AB; Schuitemaker H
    J Infect Dis; 1999 Sep; 180(3):854-7. PubMed ID: 10438379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.